Steven E. Finkelstein, MD, presented “Metastasis-Directed Therapy: Radiation Oncology Updates and Perspective” virtually during the 21st Annual Future Directions in Urology Symposium in August 2020.
How to cite: Finkelstein, Steven E. “Metastasis-Directed Therapy: Radiation Oncology Updates and Perspective” August 10th, 2020. Accessed Aug 2021. https://dev.grandroundsinurology.com/metastasis-directed-therapy-radiation-oncology-updates-and-perspective/
Metastasis-Directed Therapy: Radiation Oncology Updates and Perspective -Summary:
Steven E. Finkelstein, MD, FACRO, a radiation oncologist with Florida Cancer Affiliates in Panama City, Florida, discusses metastasis-directed therapy (MDT) as a potential treatment option for oligometastatic prostate cancer. He reviews typical management of metastatic cancer and describes how MDT can minimize the toxicity of systemic therapy, then addresses future treatment options with stereotactic ablative radiotherapy (SABR). Radiation and other local therapies are used for palliation of metastases but can also alter the course of tumor development. Dr. Finkelstein explains that MDT can be particularly beneficial in oligometastatic prostate cancer if the metastases are at a point where both the primary tumor and metastases can be treated together and likely cured. Lastly, he concludes that MDT via SABR could be employed concurrently with other treatments such as androgen deprivation therapy (ADT), chemotherapies, and radiopharmaceuticals, and that further research is necessary.
About The 2020 Virtual Future Directions in Urology Symposium
The Future Directions in Urology Symposium was founded 21 years ago to reflect on the current state of the urology community and predict trends in the treatment of urology conditions in the following 5-10 years. This conference brings together experts in the field, including urologists, medical oncologists, radiation oncologists, family practice doctors, researchers, and industry leaders to review current trends and prospects. Dr. Finkelstein presented this lecture during this year’s virtual conference in August 2020.